Showing results (101-110 of 189) with videos related to
Sort By:
Pageof 19
Psychopharmacology|January 1, 1989
Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugsS R McGurk, E D Levin, L L ButcherNeuroscience|September 1, 1992
Dopaminergic drugs reverse the impairment of radial-arm maze performance caused by lesions involving the cholinergic medial pathwayS R McGurk, E D Levin, L L ButcherBehavioural Pharmacology|April 26, 2000
AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in ratsE D Levin, C Bettegowda, J Blosser, et al.Behavioural Brain Research|August 15, 2000
Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's diseaseJ M Rusted, P A Newhouse, E D LevinNeurotoxicology and Teratology|March 1, 1992
Use of the lesion model for examining toxicant effects on cognitive behaviorE D Levin, S L Schantz, R E BowmanNeuroscience|April 3, 2002
Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memoryE D Levin, A Bradley, N Addy, et al.Pharmacology, Biochemistry, and Behavior|April 15, 2000
Nicotine enhances stimulus detection performance of middle- and old-aged rats: a longitudinal studyD M Grilly, B B Simon, E D LevinNorth Carolina Medical Journal|January 1, 1995
Nicotine as a therapeutic drugE C Westman, E D Levin, J E RoseBehavioral and Neural Biology|July 1, 1989
Nicotinic-dopaminergic relationships and radial-arm maze performance in ratsS R McGurk, E D Levin, L L ButcherNeuroscience|January 1, 1991
Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway: reversal by arecoline and differential effects of muscarinic and nicotinic antagonistsS R McGurk, E D Levin, L L ButcherPageof 19